Method for treating anxiety disorders, headache disorders, and eating disorders with psilocybin
US11564935B2 · kind B2 · utility
5Cited by
127References
27Claims
0Family size
Assignee
Inventors
- Derek John Londesbrough
- Christopher Brown
- Julian Scott Northen
- Gillian Moore
- Hemant Kashinath Patil
- David E. Nichols
- Megan CROAL
- Hans Åke ERIKSSON
- George GOLDSMITH
- Molly Tabitha HICKEY
- Shaun HURLEY
- Ekaterina MALIEVSKAIA
- Lindsey MARWOOD
- Drummond E-Wen Joe MCCULLOCH
- Laurie Emma MEDHURST
- Nathan POULSEN
- Aslihan SELIMBEYOGLU
- Anaïs SOULA
- Amanda Tan SHUXIANG
- Manon Cecile Elisabeth VERAART
- Tobias Patrick WHELAN
- Lars Christian WILDE
- Stephen Wright
Key dates
| Filing date | Dec 2, 2021 |
| Grant date | Jan 31, 2023 |
| Priority date | — |
| Expiry date | Dec 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides methods for treating a subject in need thereof comprising administering to the subject a therapeutically-effective dose of psilocybin. The methods described herein may be used to treat a variety of diseases, disorders, and conditions. For example, the methods may be used to treat anxiety disorders, eating disorders, and headache disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.